A prospective, cohort study assessing the epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines
Latest Information Update: 13 Nov 2020
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccines (Primary)
- Indications Community-acquired pneumonia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
Most Recent Events
- 17 Nov 2020 Results published in the Vaccine
- 13 Nov 2020 New trial record